MedTrace Logo

Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

NCT05751772 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-03-26

No results posted yet for this study

Summary

The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients. The knowledge score on heart failure disease and medications will be compared between two groups one month after hospitalization. The intervention group will receive a therapeutic education intervention and usual hospital care and the control group will receive only usual hospital care.

Conditions

  • Heart Failure With Reduced Ejection Fraction
  • Heart Failure; With Decompensation
  • Pharmacist-Patient Relations
  • Medication Adherence
  • Knowledge, Attitudes, Practice

Interventions

OTHER

Patient therapeutic education

The pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients is made by a clinical pharmacist and includes: 1. Targeted education on patient needs related to heart failure, heart failure medications and self-care; 2. a pre-discharge interview to consolidate key teaching messages and prepare the patient for their discharge treatment plan; 3. a telephone call the week of discharge to ensure pharmaceutical follow-up between hospital care and return home (continuity of care, transition of care).

Sponsors & Collaborators

  • Vifor Pharma

    collaborator INDUSTRY

  • Labatec Pharma SA

    collaborator INDUSTRY

  • Bayer

    collaborator INDUSTRY

  • AstraZeneca

    collaborator INDUSTRY

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Pascal Bonnabry, Professor · University of Geneva

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-13
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05751772 on ClinicalTrials.gov